Interlaboratory Reliability of 3D Gait Analysis

Last updated: August 24, 2023
Sponsor: University Ghent
Overall Status: Active - Recruiting

Phase

N/A

Condition

N/A

Treatment

Weight and height

3D gait analysis on the GRAIL

Clinical Study ID

NCT05530213
ONZ-2022-0248
  • Ages 18-65
  • All Genders
  • Accepts Healthy Volunteers

Study Summary

The purpose of this study is to determine the interlaboratory reliability of 3D gait analysis performed on healthy subjects on an instrumented treadmill in three different laboratories. This will allow us to evaluate whether the pooling of control data is feasible in future studies. This will support our ambitions to enter into future collaborations to conduct studies with larger samples. Moreover, this way we will know if we can share patient data in the future so that patients can be specifically referred to a lab with expertise on a particular evaluation, e.g. the lab in Maastricht has expertise on perturbations, UZ Gent has expertise on full-body measurements and UHasselt has expertise on balance.

During this study approximately 30 healthy subjects will be recruited (10 from each center) from the staff and students at each center. These subjects are own staff and students of the 3 centers. Each subject will undergo a 3D gait analysis at each center (at UZGent, UHasselt and UMaastricht). Therefore, each subject will be evaluated 3 times. The time between each evaluations will be a maximum of one week.

The evaluations will be performed as per standard procedure in each lab. However, a standardized model (HBM2 lower limb), an agreed walking velocity (0.9 m/s, 1.0 m/s, 1.1 m/s) and an agreed duration per recording (3 min) will be used. The same software will be used to process the collected data. 3D kinematics and kinetic time-series data of the lower limbs will be extracted as outcome data. Absolute reliability indices will be calculated in the following way: First, the standard deviation (SD) of time-series data across different gait cycles will be calculated per participant per center. The SD values across different centers per participant will then be averaged. Finally, the SD values across different participants will form the inter-laboratory reliability indices. In addition, we will use statistical parametric mapping (Anova repeated measures) to compare the full time-series data of each outcome parameter.

Eligibility Criteria

Inclusion

Inclusion Criteria:

  • healthy subjects aged 18-65 years old

Exclusion

Exclusion Criteria: Individuals cannot participate if:

  • They suffer from a neurological disorder.
  • They experience balance problems.
  • They have had surgical procedures on the legs in the past.
  • They are taking medication that may affect gait and balance. They experience leg orback pain at the time of test taking.

Study Design

Total Participants: 30
Treatment Group(s): 2
Primary Treatment: Weight and height
Phase:
Study Start date:
October 01, 2022
Estimated Completion Date:
September 01, 2024

Connect with a study center

  • University Hasselt

    Hasselt,
    Belgium

    Active - Recruiting

  • Maastricht University

    Maastricht,
    Netherlands

    Active - Recruiting

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.